A nomogram-based immune-serum scoring system predicts overall survival in patients with lung adenocarcinoma.
Qiujuan HuangTongyuan QuLisha QiChangxu LiuYuhong GuoQianru GuoGuangning LiYalei WangWenshuai ZhangWei ZhaoDanyang RenLeina SunShengguang WangBin MengBaocun SunBin ZhangWen-Juan MaWenfeng CaoPublished in: Cancer biology & medicine (2021)
Our new I-SSS can accurately and individually predict LUAD prognosis and may be used to supplement prognostication based on the TNM stage.